Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited scores highest on Earnings (69) and lowest on Price (38). Its PosiPenta is 49.01 out of 100, around the middle of similar companies.
On the Penta Grid this week, Senores Pharmaceuticals Limited is Grid #89 of 169 in the Healthcare sector in India, and Grid #1,241 of 2,389 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Limited | 49.01 | 38 | 69 | 54 | 44 | 40 |
| Sun Pharma Advanced Research Company Limited | 50.24 | 76 | 43 | 28 | 63 | 41 |
| Innova Captab Limited | 48.90 | 47 | 68 | 44 | 45 | 40 |
| FDC Limited | 59.09 | 85 | 40 | 27 | 67 | 76 |
| Nephrocare Health Services Limited | 45.95 | 29 | 63 | 44 | 47 | 47 |
| Kovai Medical Center and Hospital Limited | 69.22 | 61 | 98 | 75 | 58 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 42.30 |
| P/B ratio | 5.92 |
EEarnings
| Trailing EPS | ₹28.39 |
| Forward EPS | ₹49.60 |
NNitro
| Price | 1200.80 |
| 52-week high | 1599.00 |
| 52-week low | 706.00 |
| Fall from 52-week high | 24.9% |
TTorque
| Return on equity (ROE) (calculated) | 14.00% |
| Debt-to-equity | 0.35 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹5,530 Cr |
| Promoter holding | 54.93% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Senores Pharmaceuticals Limited's PosiPenta score?
Senores Pharmaceuticals Limited's PosiPenta is 49.01 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Senores Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Senores Pharmaceuticals Limited is Grid #89 of 169 in the Healthcare sector in India, and Grid #1,241 of 2,389 in India.
Which PosiPenta pillar is strongest for Senores Pharmaceuticals Limited?
Earnings (growth), with a score of 69 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Senores Pharmaceuticals Limited?
Price (valuation), with a score of 38 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.